Venous thromboembolic disease and pregnancy.
Marik
Paul E
PE
Division of Pulmonary and Critical Care Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA. paul.marik@jefferson.edu
Plante
Lauren A
LA
D000925:Anticoagulants / Q000627:therapeutic use*; D002585:Cesarean Section; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D020246:Venous Thrombosis / Q000150:complications
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight